Advertisement

TheBodyPRO.com Covers CROI 2017
Myles Helfand
Long-acting antiretrovirals: Are they the future of HIV treatment or will the future pass them by? Researcher Charles W. Flexner recently addressed several common myths.

ABOUT THIS CONFERENCE: The annual Conference on Retroviruses and Opportunistic Infections (CROI) features the latest, most important discoveries in HIV research and science. This year's meeting brings together over 4,000 HIV/AIDS researchers, clinicians and experts, from across the globe. TheBodyPRO.com's coverage of CROI 2017 includes study and presentation summaries, as well as analyses from study authors and leading HIV clinicians/researchers. Please note: TheBodyPRO.com is an independent website not associated with the conference. (Credit: pabradyphoto for iStock via Thinkstock.)


Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article


Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.